Common Neonatal Skin Lesions
The most common neonatal skin lesions are benign, self-limited conditions including sebaceous gland hyperplasia (89%), Epstein pearls (89%), Mongolian spots (85%), erythema toxicum neonatorum (23%), and salmon patches (21%), with over 95% of newborns exhibiting some cutaneous finding in the first days of life. 1, 2
Most Prevalent Physiological Findings
The following benign conditions are extremely common and require no treatment:
- Sebaceous gland hyperplasia appears in approximately 89% of newborns as tiny yellow-white papules on the face 1
- Epstein pearls occur in 89% as white keratin-filled cysts on the palate 1
- Mongolian spots (dermal melanocytosis) are present in 85% of newborns, appearing as blue-gray patches typically over the sacrum and buttocks 1
- Knuckle pigmentation affects 58% of neonates 1
- Linea nigra is visible in 45% of newborns 1
- Hypertrichosis (lanugo) occurs in 35-39% of infants 3, 1
Common Transient Neonatal Pustular Eruptions
These benign pustular conditions are frequently mistaken for infections but are self-resolving:
- Erythema toxicum neonatorum is the most common pustular eruption, affecting 23% of newborns, with significantly higher prevalence in term versus preterm infants 4, 5, 1
- Miliaria crystallina appears in 3% of neonates as superficial clear vesicles 1
- Transient neonatal pustular melanosis presents as pustules that rupture leaving hyperpigmented macules 5, 2
- Neonatal cephalic pustulosis manifests as inflammatory papules and pustules on the face 5
Vascular Birthmarks
- Salmon patches (nevus simplex) occur in 21% of newborns as pink patches on the glabella, eyelids, or nape 3, 1
- Infantile hemangiomas affect up to 5% of infants and are the most common benign tumor of infancy, with most being small and self-resolving 6
High-Risk Hemangiomas Requiring Early Referral
Infants with potentially problematic hemangiomas should be referred by 1 month of age because the most rapid growth occurs between 1-3 months, and growth is typically complete by 5 months 6. High-risk features include:
- Facial location (risk of permanent scarring/disfigurement) 6
- Periorbital location (risk of functional impairment) 6
- Airway or hepatic involvement 6
- Large size with potential for ulceration 6
When systemic treatment is indicated, propranolol 2-3 mg/kg/day is the drug of choice, typically continued for at least 6 months and often until 12 months of age 6.
Congenital Melanocytic Nevi (CMN)
CMN occur in 1-3.6% of newborns and are classified by projected adult size 6:
- Small CMN: <1.5 cm
- Medium CMN: 1.5-20 cm
- Large CMN: 20-40 cm
- Giant CMN: >40 cm
Risk Stratification for CMN
Giant CMN (>40 cm projected adult size), multiple CMN, trunk location, and numerous satellite nevi carry the highest risk for melanoma (0.7-1.7% lifetime risk) and neurocutaneous melanosis 6. Brain and spine MRI is the preferred screening modality for high-risk patients 6.
Pigmented Lesions
- Café-au-lait macules appear in 1.3% of newborns 1
- Congenital melanocytic nevi are present in 1.9% of neonates 1
Critical Differentiating Features
The key clinical challenge is distinguishing benign pustular eruptions from serious infectious conditions requiring immediate treatment 2:
Benign pustular eruptions typically show:
Infectious pustular eruptions requiring urgent evaluation:
- Bullous impetigo (bacterial) 2
- Congenital syphilis (bacterial) 2
- Neonatal herpes simplex virus (viral) 2
- Congenital/neonatal candidiasis (fungal) 2
Common Pitfalls to Avoid
- Do not perform unnecessary diagnostic procedures or treatments for benign physiological findings that cause parental concern but are self-limited 4, 1
- Do not delay referral of high-risk hemangiomas beyond 1 month of age, as the window for optimal treatment is narrow 6
- Do not assume all pustular eruptions are benign—maintain high suspicion for infectious etiologies in systemically ill neonates 2
- Do not dismiss pruritus in large CMN as malignant transformation—it is usually benign and responds to emollients and topical corticosteroids 6